01 6ARDELYX INC
01 610940146
01 6Blank
01 6Blank
01 62034-04-10
Patent Expiration Date : 2034-04-10
US Patent Number : 10940146
Drug Substance Claim :
Drug Product Claim :
Application Number : 213931
Patent Use Code : U-3736
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-10
Patent Expiration Date : 2034-04-10
US Patent Number : 10940146
Drug Substance Claim :
Drug Product Claim :
Application Number : 213931
Patent Use Code : U-3736
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-10
Patent Expiration Date : 2034-04-10
US Patent Number : 10940146
Drug Substance Claim :
Drug Product Claim :
Application Number : 213931
Patent Use Code : U-381
Delist Requested :
Patent Use Description : TREATMENT OF HYPERPHOS...
Patent Expiration Date : 2034-04-10
Patent Expiration Date : 2034-04-10
US Patent Number : 10940146
Drug Substance Claim :
Drug Product Claim :
Application Number : 213931
Patent Use Code : U-381
Delist Requested :
Patent Use Description : TREATMENT OF HYPERPHOS...
Patent Expiration Date : 2034-04-10
Patent Expiration Date : 2034-04-10
US Patent Number : 10940146
Drug Substance Claim :
Drug Product Claim :
Application Number : 213931
Patent Use Code : U-381
Delist Requested :
Patent Use Description : TREATMENT OF HYPERPHOS...
Patent Expiration Date : 2034-04-10
Patent Expiration Date : 2034-04-10
US Patent Number : 10940146
Drug Substance Claim :
Drug Product Claim :
Application Number : 213931
Patent Use Code : U-3736
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-10
